OpenVSafe by OpenVAERS
Search V-safe

5K7-22694-97535

3 vaccinations 2 coded responses 13 check-ins 1 free-text entry 3 call cases
Sex
Female
Age at first dose
31-35
ZIP prefix
347 / FL
Registered
2022-01-05
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Possible VAERS report

VAERS IDConfidenceScoreRunner-upShared symptomsDose StateVAERS vaccinated / onset / receivedCall case
2548829 (opens in a new window) high 9 / 11 — 2 of 17 VAERS symptoms same dose (3) FL matches 2022-01-02 / 2022-01-12 / 2023-01-03
received the same day as the last call
 case 68862

From the VAERS matching of call center cases (loader/vaers_match_*). Only the best match is shown, and only if it scores 8 or more out of 11. The score adds up timing (VAERS received soon after the call center contact), dose and shared symptoms; state only breaks ties. Confidence is high when the score is 8+ and at least 3 points ahead of the runner-up, medium when 5+ and 2 ahead, otherwise low. A match is a likely link, not a confirmed one.

Timeline

  1. 2021-04-14
    Dose 1 — Pfizer-BioNTech
  2. 2021-05-04
    Dose 2 — Pfizer-BioNTech
  3. 2022-01-02
    Dose 3 — Pfizer-BioNTech
  4. 2022-01-05
    Registered in v-safe
  5. 2022-01-05
    Health check-in — days 1–6 daily, dose 3
    Feeling: Poor · Site: Pain, Redness, Swelling, Itching · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Rash, not including the immediate area around the injection site · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Adult check-in
  6. 2022-01-05
    Report sent to call center — days 1–6 daily, dose 3
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Telehealth, virtual health, or email health consultation · 1 call case(s)
  7. 2022-01-06
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · Site: Redness, Itching · Muscle or body aches, Fatigue or tiredness, Rash, not including the immediate area around the injection site
    Adult check-in
  8. 2022-01-06
  9. 2022-01-07
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · Site: Pain, Redness, Swelling · Muscle or body aches, Fatigue or tiredness, Rash, not including the immediate area around the injection site
    Adult check-in
  10. 2022-01-08
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · Site: Redness, Itching · Rash, not including the immediate area around the injection site
    Adult check-in
  11. 2022-01-09
    Health check-in — day 7, dose 3
    Feeling: Good · Rash, not including the immediate area around the injection site
    Adult check-in
  12. 2022-01-16
    Survey response — day 14, dose 3
    MedDRA: Rash, Rash papular — Feeling: Fair · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Free text: Painful, raised rash on back of lower legs
    MedDRA releases: 2024-11 · check-in free text available
  13. 2022-01-16
    Report sent to call center — day 14, dose 3
    Get care from a doctor or other healthcare professional
    Telehealth, virtual health, or email health consultation · 1 call case(s)
  14. 2022-01-17
  15. 2022-01-23
    Health check-in — day 21, dose 3
    Feeling: Good
    Adult check-in
  16. 2022-01-30
    Health check-in — day 28, dose 3
    Feeling: Good
    Adult check-in
  17. 2022-02-06
    Health check-in — day 35, dose 3
    Feeling: Good
    Adult check-in
  18. 2022-02-13
    Health check-in — day 42, dose 3
    Feeling: Good
    Adult check-in
  19. 2022-04-03
    Health check-in — 3 months, dose 3
    Feeling: Good
    Adult check-in
  20. 2022-07-03
    Health check-in — 6 months, dose 3
    Feeling: Good
    Adult check-in
  21. 2023-01-02
    Survey response — 12 months, dose 3
    MedDRA: COVID-19 — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    MedDRA releases: 2024-11
  22. 2023-01-02
    Report sent to call center — 12 months, dose 3
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Telehealth, virtual health, or email health consultation · 1 call case(s)
  23. 2023-01-03
    Call successful
    Completed over the phone
  24. 2023-01-03
    Call successful
    Completed over the phone
  25. 2023-01-03
    Call successful
    Completed over the phone

Vaccinations

DoseDateManufacturerCo-administered
12021-04-14Pfizer-BioNTech No
22021-05-04Pfizer-BioNTech No
32022-01-02Pfizer-BioNTech No

Call center

ReportedOutcomeVAERS-related outcome
2022-01-05 Successful
2023-01-03
 Completed over the phone
2022-01-16 Successful
2023-01-03
 Completed over the phone
2023-01-02 Successful
2023-01-03
 Completed over the phone

Free text

Release 10 — day 14, dose 3

2022-01-16

Symptoms: Painful, raised rash on back of lower legs

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDCOVID-19 · · ✓
SDRash · · ✓
SDRash papular · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release

Loading…